Roche Holding AG (RHHVF)
OTCMKTS · Delayed Price · Currency is USD
393.00
+4.25 (1.09%)
Jun 4, 2026, 9:30 AM EST
Roche Holding AG Employees
Roche Holding AG had 103,249 employees as of December 31, 2024. The number of employees decreased by 356 or -0.34% compared to the previous year.
Employees
103,249
Change (1Y)
-356
Growth (1Y)
-0.34%
Revenue / Employee
$773,849
Profits / Employee
$157,320
Market Cap
328.28B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 103,249 | -356 | -0.34% |
| Dec 31, 2023 | 103,605 | -8 | -0.01% |
| Dec 31, 2022 | 103,613 | 2,693 | 2.67% |
| Dec 31, 2021 | 100,920 | -545 | -0.54% |
| Dec 31, 2020 | 101,465 | 3,730 | 3.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| American Oncology Network | 1,914 |
| Glass House Brands | 426 |
| Northwest Biotherapeutics | 105 |
| Silence Therapeutics | 88 |
| Elite Pharmaceuticals | 68 |
| Vaxart | 65 |
| CytoDyn | 13 |
| Tian'an Technology Group | 10 |
Roche Holding AG News
- 2 hours ago - Roche rapidly develops a PCR test for Ebola within six days as rare Bundibugyo virus drives urgent need for detection - PRNewsWire
- 3 hours ago - Roche chairman likens US tariff policy to 'blackmail' - Reuters
- 1 day ago - Roche Holding AG Transcript: Investor update - Transcripts
- 1 day ago - Roche Holding AG Slides: Investor update - Filings
- 2 days ago - FDA Accepts New Drug Application for Genentech's Giredestrant in ER-Positive Early-Stage Breast Cancer, the First and Only Oral SERD With Positive Phase III Results in the Curative Setting - Business Wire
- 2 days ago - FDA accepts New Drug Application for Roche's giredestrant in ER-positive early-stage breast cancer, the first and only oral SERD with positive phase III results in the curative setting - GlobeNewsWire
- 3 days ago - Roche to present new data advancing its obesity portfolio at the American Diabetes Association's 2026 Scientific Sessions - GlobeNewsWire
- 3 days ago - Genentech to Present New Data Advancing Its Obesity Portfolio at the American Diabetes Association's 2026 Scientific Sessions - Business Wire